AVE 25.0% 0.3¢ avecho biotechnology limited

it`s the balance sheet stupid, page-105

  1. 5,819 Posts.
    lightbulb Created with Sketch. 338
    Jeeper, POH were about to do phase 2/3 trials with diclofenac when the fda raised the red flag about Diclofenac due to concerns about side affects.

    Poh put a hold on its program. Does that mean they stopped negotiations? In fact the concerns strengthen TPM/diclofenacs case as less active would be required for theraputic effect.

    Deals do take a long time to bed down and POH tend to have surprises tucked away. I hope this is one of them.

    Jeeps you know about the above news, maybe you should be selling out, you seem to have run out of the enourmous amount of patience that POH demands of us. ;-) lol

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.